House Foreign Affairs Committee approves FY13 Foreign Relations Authorization Act

NewsGuard 100/100 Score

"The House Foreign Affairs Committee on Wednesday approved a $16.2 billion State Department authorization bill [.pdf] after reaching bipartisan consensus," The Hill's "Global Affairs" blog reports, adding, "The bill passed by voice vote in under a minute, in stark contrast with last year's record 30-hour markup where Democrats and Republicans battled on everything from funding for abortion providers to aid to Pakistan" (Pecquet, 6/27). The FY13 Foreign Relations Authorization Act (HR 6018) "authorizes FY13 appropriations for the State Department and a few other International Affairs programs at largely current (FY12) funding levels, a very positive development in the current budget environment," according to a U.S. Global Leadership Coalition budget update (Lester, 6/27). The hearing's opening statement from Committee Chair Ileana Ros-Lehtinen (R-Fla.) and a summary of the bill are available online (6/27).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.